Welcome to Crene Biotechnology!

+86-576-88205808

Product :

QNZ EVP4593

QNZ EVP4593 545380-34-5
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:QNZ EVP4593 Purity:98% min
CAS NO:545380-34-5 Solubility:DMSO : ≥ 37 mg/mL (103.81 mM)
Molecular Formula:C22H20N4O Package:Package according to customer requirements.
Molecular Weight:356.420 Storage:Store at -20℃
Quality control
COA
Remarks

EVP4593, also known as QNZ and CAY10470, is an inhibitor of NF-κB activation with an IC50 of 11 nM in human Jurkat cells. EVP4593 reduced the number of lysosomes/autophagosomes and SOC currents in HD GMSLNs and exerted neuroprotective effects during cell aging. EVP4593 may be a promising anti-HD drug.

Properties:
Appearance & Physical State: White solid
Density: 1.275g/cm3
Melting Point: 169-175ºC
Boiling Point: 602ºC at 760 mmHg
Flash Point: 317.9ºC
Refractive Index: 1.713

 

 

 

NF-κB Inhibitors Related Products:

Bortezomib; Bortezomib pinanediol ester; TPCA-1; Bardoxolone methyl; Curcumin; Triptolide; JSH-23; Benfotiamine; Omaveloxolone; Erdosteine

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China